Revvity Inc vs Vanguard S&P 500 ETF — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Vanguard S&P 500 ETF trades at $687.63. The key difference: Revvity Inc pays a 0.26% dividend while Vanguard S&P 500 ETF pays none, and Vanguard S&P 500 ETF is trading nearer its 52-week high, Revvity Inc nearer its low. Which is the better fit depends on your goals.
| RVTY | VOO | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $117.75 | $698.29 |
52-Week Low | $82.26 | $571.45 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →